Welcome to LookChem.com Sign In|Join Free
  • or
(2-TERT-BUTOXY)BENZALDEHYDE is a chemical compound characterized by a benzene ring with a tert-butoxy group and an aldehyde functional group. It is known for its increased steric hindrance due to the tert-butoxy group, which influences its reactivity and stability. This versatile chemical is a valuable building block in the synthesis of organic compounds and serves as a fragrance and flavoring agent in the food and cosmetic industry.

35129-22-7

Post Buying Request

35129-22-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

35129-22-7 Usage

Uses

Used in Organic Synthesis:
(2-TERT-BUTOXY)BENZALDEHYDE is used as a building block for the synthesis of various organic compounds, contributing to the development of new chemical entities with potential applications in different industries.
Used in Fragrance and Flavoring Industry:
(2-TERT-BUTOXY)BENZALDEHYDE is used as a fragrance and flavoring agent in the food and cosmetic industry, providing unique scents and flavors to products.
Used in Pharmaceutical Production:
(2-TERT-BUTOXY)BENZALDEHYDE is a potential intermediate in the production of pharmaceuticals, playing a crucial role in the development of new drugs and therapeutic agents.
Used in Agrochemical Production:
(2-TERT-BUTOXY)BENZALDEHYDE is also a potential intermediate in the production of agrochemicals, contributing to the development of new pesticides and other agricultural chemicals.
Used in Research and Development:
(2-TERT-BUTOXY)BENZALDEHYDE is utilized in research and development for studying its properties, reactivity, and potential applications in various fields.
It is important to handle and use (2-TERT-BUTOXY)BENZALDEHYDE with caution due to its potential irritant and harmful effects if not properly managed.

Check Digit Verification of cas no

The CAS Registry Mumber 35129-22-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,5,1,2 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 35129-22:
(7*3)+(6*5)+(5*1)+(4*2)+(3*9)+(2*2)+(1*2)=97
97 % 10 = 7
So 35129-22-7 is a valid CAS Registry Number.

35129-22-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[(2-methylpropan-2-yl)oxy]benzaldehyde

1.2 Other means of identification

Product number -
Other names 2-(2-tert-butoxyphenyl)benzaldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:35129-22-7 SDS

35129-22-7Relevant academic research and scientific papers

An SNAr approach to sterically hindered ortho -alkoxybenzaldehydes for the synthesis of olefin metathesis catalysts

Engle, Keary M.,Luo, Shao-Xiong,Grubbs, Robert H.

, p. 4213 - 4220 (2015/05/05)

A three-step procedure has been developed for preparing ortho-alkoxybenzaldehydes from ortho-fluorobenzaldehydes that tolerates the use of sterically hindered sodium alkoxide nucleophiles. The protocol is modular and operationally convenient. The ortho-alkoxybenzaldehyde products can be converted in one additional step to ortho-alkoxystyrenes by a Wittig reaction. These styrenes are precursors to the chelating benzylidene moiety in a proposed series of novel ruthenium complexes for use in olefin metathesis. Chelation with three representative styrenes has been demonstrated.

COMPOSITIONS AND METHODS FOR IMAGING TISSUES, ORGANS AND TUMORS

-

, (2012/11/07)

The present invention relates to compounds and related technetium and rhenium complexes thereof which are suitable for imaging or therapeutic treatment of tissues, organs, or tumors. In another embodiment, the invention relates to methods of imaging tissues, organs, or tumors using radiolabeled metal complexes, particularly tissues, organs, or tumors which express certain receptors to which the compounds or complexes of the invention have an affinity. The present invention also relates to methods of treating cancer, particularly those cancer lines which express certain receptors to which the compounds or complexes of the invention have an affinity. In yet another embodiment, the present invention provides methods of imaging and/or inhibiting receptors or neuroreceptors using compounds or complexes of the invention which have an affinity for the receptor or neuroreceptor to be imaged and/or inhibited.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 35129-22-7